UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8666) 8666
science & technology (6731) 6731
life sciences & biomedicine (6669) 6669
female (6526) 6526
remission induction (6496) 6496
male (5928) 5928
middle aged (5323) 5323
adult (4975) 4975
aged (4123) 4123
antineoplastic combined chemotherapy protocols - therapeutic use (4037) 4037
oncology (3801) 3801
biological and medical sciences (3306) 3306
medical sciences (3299) 3299
antineoplastic combined chemotherapy protocols - adverse effects (2929) 2929
treatment outcome (2868) 2868
chemotherapy (2596) 2596
hematology (2534) 2534
pharmacology. drug treatments (1976) 1976
adolescent (1914) 1914
antineoplastic agents (1670) 1670
cancer (1462) 1462
survival rate (1439) 1439
combined modality therapy (1390) 1390
disease-free survival (1329) 1329
follow-up studies (1319) 1319
aged, 80 and over (1213) 1213
prognosis (1192) 1192
drug administration schedule (1158) 1158
retrospective studies (1156) 1156
child (1112) 1112
abridged index medicus (1067) 1067
neoplasm staging (1064) 1064
survival analysis (1042) 1042
care and treatment (982) 982
induction chemotherapy (968) 968
antineoplastic combined chemotherapy protocols - administration & dosage (960) 960
cisplatin - administration & dosage (910) 910
recurrence (892) 892
young adult (862) 862
child, preschool (837) 837
antineoplastic agents - therapeutic use (831) 831
antineoplastic agents - adverse effects (797) 797
cyclophosphamide - administration & dosage (775) 775
time factors (763) 763
cytarabine - administration & dosage (761) 761
hematologic and hematopoietic diseases (753) 753
leukemia, myeloid, acute - drug therapy (749) 749
transplantation (741) 741
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (699) 699
risk factors (678) 678
prospective studies (673) 673
medicine & public health (666) 666
doxorubicin - administration & dosage (653) 653
tumors (652) 652
etoposide - administration & dosage (639) 639
vincristine - administration & dosage (603) 603
fluorouracil - administration & dosage (574) 574
hematology, oncology and palliative medicine (557) 557
research (548) 548
analysis (547) 547
health aspects (547) 547
infant (539) 539
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (531) 531
leukemia (511) 511
patients (508) 508
lung neoplasms - drug therapy (504) 504
cisplatin - adverse effects (497) 497
neutropenia - chemically induced (490) 490
antineoplastic agents - administration & dosage (488) 488
dose-response relationship, drug (479) 479
salvage therapy (467) 467
remission induction - methods (466) 466
hematopoietic stem cell transplantation (458) 458
acute myeloid leukemia (457) 457
drug therapy (457) 457
cyclophosphamide - adverse effects (454) 454
radiotherapy (443) 443
leukemia, myeloid, acute - mortality (438) 438
disease progression (430) 430
pediatrics (416) 416
kaplan-meier estimate (409) 409
surgery (402) 402
general & internal medicine (393) 393
infusions, intravenous (391) 391
prednisone - administration & dosage (391) 391
transplantation, autologous (387) 387
cytarabine - adverse effects (386) 386
clinical trials (385) 385
doxorubicin - adverse effects (376) 376
medicine, general & internal (376) 376
stem cells (376) 376
immunology (374) 374
induction chemotherapy - methods (368) 368
methotrexate - administration & dosage (368) 368
drug evaluation (361) 361
transplantation, homologous (352) 352
pharmacology & pharmacy (343) 343
breast neoplasms - drug therapy (341) 341
etoposide - adverse effects (340) 340
vincristine - adverse effects (338) 338
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8500) 8500
Japanese (215) 215
Chinese (180) 180
French (79) 79
German (77) 77
Russian (66) 66
Spanish (51) 51
Polish (19) 19
Hungarian (17) 17
Portuguese (10) 10
Italian (9) 9
Czech (5) 5
Dutch (4) 4
Serbian (3) 3
Ukrainian (3) 3
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 32, pp. 3651 - 3658
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2014, Volume 167, Issue 3, pp. 394 - 401
Burkitt leukaemia | children | chemotherapy | rituximab | Burkitt lymphoma | Rituximab | Chemotherapy | Children | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Consolidation Chemotherapy | Cytarabine - adverse effects | Genes, myc | Typhlitis - chemically induced | Lymphoma, B-Cell - genetics | Cyclophosphamide - adverse effects | Immunotherapy | Burkitt Lymphoma - genetics | Vincristine - administration & dosage | Female | Maintenance Chemotherapy | Child | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Lymphoma, B-Cell - drug therapy | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Etoposide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Adolescent | Vincristine - adverse effects | Methotrexate - administration & dosage | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Central Nervous System Neoplasms - drug therapy | Doxorubicin - adverse effects | Lymphomas | Leukemia | Central nervous system | Cancer | Index Medicus | Burkitt Leukaemia | Burkitt Lymphoma | adolescents
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 18, pp. 1728 - 1740
Journal Article
Pediatric neurology, ISSN 0887-8994, 2015, Volume 53, Issue 1, pp. 31 - 46
Journal Article
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Hematology | Science & Technology | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1269 - 1278
Journal Article
Supportive care in cancer, ISSN 0941-4355, 11/2020, Volume 28, Issue 11, pp. 5335 - 5342
Journal Article